Seungbeom Ko

Seungbeom Ko

Auto-generated profile, based on publicly available information

Seungbeom Ko

Medical University of South Carolina 1 Department of Biochemistry and Molecular Biology Charleston, SC 29425

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Journal of Cell Science
Verified
Journal Article
Open access
KMKyung-Won Min
Kyung-Won Min
KCKyoung-Min Choi
Kyoung-Min Choi
HMHyejin Mun
Hyejin Mun
SKSeungbeom Ko
Seungbeom Ko
JLJi Won Lee
Ji Won Lee
Je-Hyun YoonJe-Hyun Yoon
Je-Hyun Yoon
Argonaute (AGO), a component of RNA-induced silencing complexes (RISCs), is a representative RNA-binding protein (RBP) known to bind with mature microRNAs (miRNAs) and is directly involved in post-transcriptional gene silencing. However, despite the biological significance of miRNAs, the roles of other miRNA-binding proteins (miRBPs) remain unclear in the regulation of miRNA loading, dissociation from RISCs and extracellular release. In this study, we performed protein arrays to profile miRBPs and identify 118 RBPs that directly bind to miRNAs. Among those proteins, the RBP quaking (QKI) inhibits extracellular release of the mature microRNA let-7b by controlling the loading of let-7b into extracellular vesicles via additional miRBPs such as AUF1 (also known as hnRNPD) and hnRNPK. The enhanced extracellular release of let-7b after QKI depletion activates Toll-like receptor 7 (TLR7) and promotes the production of proinflammatory cytokines in recipient cells, leading to brain inflammation in the mouse cortex. Thus, this study reveals the contribution of QKI to the inhibition of brain inflammation via regulation of extracellular let-7b release.

24 August 2022 in Biomaterials
Verified
Journal Article
Closed access
JLJaiwoo Lee
Jaiwoo Lee
QLQuoc-Viet Le
Quoc-Viet Le
SKSeungbeom Ko
Seungbeom Ko
KSkang sungtaek
kang sungtaek
RMRobert B. Macgregor
Robert B. Macgregor
YOYu-Kyoung Oh
Yu-Kyoung Oh

19 March 2018 in Nano Research
Verified
Journal Article
Closed access
PDF file
SKSeungbeom Ko
Seungbeom Ko
Gayong ShimGayong Shim
Gayong Shim
JKJinyoung Kim
Jinyoung Kim
YOYu-Kyoung Oh
Yu-Kyoung Oh
Here, we report that chemokine-mimetic plerixafor derivatives could govern tumor-specific delivery and functional effects of nanomaterials. Reduced graphene oxide (rGO) nanosheets were used as a model functional nanomaterial, and plerixafor-conjugated lipid (PL/rGO) or a benzylcyclam derivative of plerixafor-conjugated lipid (BPL/rGO) was physically adsorbed onto the surface of rGO. The cellular uptake of surface-modified rGO was dependent on overexpression of the CXCR4 chemokine receptor on cancer cells. In KB cells, the binding affinity of BPL/rGO for CXCR4 was 6.8-fold greater than that of PL/rGO. Notably, cellular uptake patterns correlated with in vitro photothermal anticancer efficacy. The tumor distribution of BPL/rGO was higher than that of PL/rGO and plain rGO in mice bearing CXCR4-overexpressing tumors, whereas the distribution of the various rGO forms was similar in mice harboring CXCR4-negative tumors. Moreover, complete photothermal tumor ablation was observed in BPL/rGO-treated mice bearing CXCR4-positive KB cell tumors, but not in CXCR4-negative MCF-7 cell tumors. These results provide evidence that BPL can be used to enhance the delivery of nanomaterials to CXCR4-overexpressing tumors. Chemokine-mimetic BPL can be further applied for nanomaterial-based delivery of photosensitizers, anticancer drugs, or diagnostic tumor imaging agents in CXCR4-overexpressing cancer patients.

1 January 2022 in Journal of Lipid and Atherosclerosis
Verified
Journal Article
Open access
PDF file
SKSeungbeom Ko
Seungbeom Ko
EYEunbyul Yeom
Eunbyul Yeom
YCYoo Lim Chun
Yoo Lim Chun
HMHyejin Mun
Hyejin Mun
MHMarina Howard-McGuire
Marina Howard-McGuire
Je-Hyun YoonJe-Hyun Yoon
Je-Hyun Yoon
Ko S, et al. J Lipid Atheroscler. 2022 Jan;11(1):55-72. https://doi.org/10.12997/jla.2022.11.1.55